Journal of Cardiac Failure最新文献

筛选
英文 中文
Celebrate 30 Years of HFSA at ASM 2025 – Reunite, Reflect, and Reimagine the Future of Heart Failure 在ASM 2025上庆祝HFSA 30周年-重聚,反思和重新构想心力衰竭的未来
IF 8.2 2区 医学
Journal of Cardiac Failure Pub Date : 2025-09-01 DOI: 10.1016/j.cardfail.2025.08.001
{"title":"Celebrate 30 Years of HFSA at ASM 2025 – Reunite, Reflect, and Reimagine the Future of Heart Failure","authors":"","doi":"10.1016/j.cardfail.2025.08.001","DOIUrl":"10.1016/j.cardfail.2025.08.001","url":null,"abstract":"","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 9","pages":"Pages 1493-1495"},"PeriodicalIF":8.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145020932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2023 Update of the Japanese Heart Failure Society Scientific Statement on BNP and NT-proBNP Levels in Heart Failure Practice 2023日本心力衰竭学会关于心力衰竭实践中BNP和NT-proBNP水平的科学声明更新。
IF 8.2 2区 医学
Journal of Cardiac Failure Pub Date : 2025-09-01 DOI: 10.1016/j.cardfail.2025.03.005
MASATOSHI MINAMISAWA MD, PhD , TOSHIHISA ANZAI MD, PhD , TAKAYUKI INOMATA MD, PhD , KOICHIRO KINUGAWA MD, PhD , YASUSHI SAKATA MD, PhD , NAOKI SATO MD, PhD , HIROYUKI TSUTSUI MD, PhD , KAZUHIRO YAMAMOTO MD, PhD , MICHIHIRO YOSHIMURA MD, PhD , YOSHIHIKO SAITO MD, PhD , KOICHIRO KUWAHARA MD, PhD
{"title":"2023 Update of the Japanese Heart Failure Society Scientific Statement on BNP and NT-proBNP Levels in Heart Failure Practice","authors":"MASATOSHI MINAMISAWA MD, PhD ,&nbsp;TOSHIHISA ANZAI MD, PhD ,&nbsp;TAKAYUKI INOMATA MD, PhD ,&nbsp;KOICHIRO KINUGAWA MD, PhD ,&nbsp;YASUSHI SAKATA MD, PhD ,&nbsp;NAOKI SATO MD, PhD ,&nbsp;HIROYUKI TSUTSUI MD, PhD ,&nbsp;KAZUHIRO YAMAMOTO MD, PhD ,&nbsp;MICHIHIRO YOSHIMURA MD, PhD ,&nbsp;YOSHIHIKO SAITO MD, PhD ,&nbsp;KOICHIRO KUWAHARA MD, PhD","doi":"10.1016/j.cardfail.2025.03.005","DOIUrl":"10.1016/j.cardfail.2025.03.005","url":null,"abstract":"<div><div>This revised 2023 statement on blood brain (B-type) natriuretic peptide (BNP) and N-terminal prohormone of brain (B-type) natriuretic peptide (NT-proBNP) represents an expert consensus that aims to enhance efficient referral from general practitioners or non-cardiovascular specialists, providing a comprehensive, up-to-date perspective on BNP and NT-proBNP in the diagnosis and management of heart failure, with a focus on the following two major modifications: (1) Changes regarding cutoff values for BNP and NT-proBNP (criteria for heart failure diagnosis and referral criteria to cardiovascular specialists); and (2) Content related to heart failure management using BNP and NT-proBNP (BNP-guided therapy).</div></div>","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 9","pages":"Pages 1453-1459"},"PeriodicalIF":8.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143692232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recovery of Left Ventricular Ejection Fraction in Patients With Anthracycline-Induced Cardiomyopathy: A Contemporary Cohort Study 蒽环类药物引起的心肌病患者左心室射血分数的恢复-一项当代队列研究。
IF 8.2 2区 医学
Journal of Cardiac Failure Pub Date : 2025-09-01 DOI: 10.1016/j.cardfail.2024.12.012
OSNAT ITZHAKI BEN ZADOK MD, MSc , PANAGIOTIS SIMITSIS MD , ANJU NOHRIA MD, MSc
{"title":"Recovery of Left Ventricular Ejection Fraction in Patients With Anthracycline-Induced Cardiomyopathy: A Contemporary Cohort Study","authors":"OSNAT ITZHAKI BEN ZADOK MD, MSc ,&nbsp;PANAGIOTIS SIMITSIS MD ,&nbsp;ANJU NOHRIA MD, MSc","doi":"10.1016/j.cardfail.2024.12.012","DOIUrl":"10.1016/j.cardfail.2024.12.012","url":null,"abstract":"<div><h3>Background</h3><div>Data on left ventricular ejection fraction (LVEF) recovery in patients with anthracycline-induced cardiomyopathy (AIC) are limited.</div></div><div><h3>Objectives</h3><div>To evaluate LVEF recovery rate, its predictors and its association with cardiovascular outcomes in a contemporary and diverse cohort with AIC.</div></div><div><h3>Methods</h3><div>This retrospective study analyzed patients diagnosed with AIC from 2010–2023 at 2 U.S. university hospitals and an affiliated cancer center. LVEF recovery, defined as ≥ 10% improvement in LVEF to a value ≥ 50% within 3 years of AIC detection, was assessed by using Cox proportional-hazards accounting for competing risks. The association between LVEF recovery and the composite of heart failure (HF) hospitalizations, mechanical circulatory support, heart transplantation, or cardiovascular death was assessed by using Cox regression analysis with LVEF recovery as a time-dependent factor.</div></div><div><h3>Results</h3><div>Among 167 patients with anthracycline-induced cardiomyopathy (AIC) (median age 67 [Q1, Q3: 53, 74] years, 53% female), the majority had lymphoma (55%) or breast cancer (23%). The median time from first anthracycline exposure to AIC detection was 631 (219, 3569) days, and the median LVEF was 38% (29%, 45%). At the detection of AIC, 69% had symptomatic HF. LVEF recovered in 38% (n = 63) at a median of 349 (137, 691) days from AIC detection. Age ≥ 60 years at anthracycline exposure, non-white race, diabetes mellitus, longer interval between anthracycline exposure and AIC detection, and LV dilation were associated with a lower likelihood of recovery, while statin use and AIC detection after 2022 were associated with a higher likelihood of recovery. LVEF recovery was not associated with cardiovascular outcomes.</div></div><div><h3>Conclusion</h3><div>In this contemporary and diverse AIC cohort, 38% achieved LVEF recovery. Routine screening for AIC and statin therapy may improve recovery rates.</div></div>","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 9","pages":"Pages 1379-1389"},"PeriodicalIF":8.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143023624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Recipe for Heart Failure? Time to Recognize the Inflammatory Diet as a Risk Factor for Heart Failure 心脏衰竭的秘诀?是时候认识到炎症性饮食是心力衰竭的危险因素了。
IF 8.2 2区 医学
Journal of Cardiac Failure Pub Date : 2025-09-01 DOI: 10.1016/j.cardfail.2025.07.002
ADITYA MEHTA MD , ATSUSHI MIZUNO MD , HOWARD EISEN MD
{"title":"A Recipe for Heart Failure? Time to Recognize the Inflammatory Diet as a Risk Factor for Heart Failure","authors":"ADITYA MEHTA MD ,&nbsp;ATSUSHI MIZUNO MD ,&nbsp;HOWARD EISEN MD","doi":"10.1016/j.cardfail.2025.07.002","DOIUrl":"10.1016/j.cardfail.2025.07.002","url":null,"abstract":"","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 9","pages":"Pages 1450-1452"},"PeriodicalIF":8.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144707630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment With mTOR Inhibitors as Primary Immunosuppression After Combined Heart and Kidney Transplantation mTOR抑制剂作为心脏和肾脏联合移植后原发性免疫抑制的治疗。
IF 8.2 2区 医学
Journal of Cardiac Failure Pub Date : 2025-09-01 DOI: 10.1016/j.cardfail.2024.10.451
HILMI ALNSASRA MD , RABEA ASLEH MD, PhD, MHA , FOUAD KHALIL MD , ELIAS AKIKI MD , ALEXANDROS BRIASOULIS MD, PhD , PATRICK G. DEAN MD , ANDREW J. BENTALL MD, MBChB , SUDHIR S. KUSHWAHA MD
{"title":"Treatment With mTOR Inhibitors as Primary Immunosuppression After Combined Heart and Kidney Transplantation","authors":"HILMI ALNSASRA MD ,&nbsp;RABEA ASLEH MD, PhD, MHA ,&nbsp;FOUAD KHALIL MD ,&nbsp;ELIAS AKIKI MD ,&nbsp;ALEXANDROS BRIASOULIS MD, PhD ,&nbsp;PATRICK G. DEAN MD ,&nbsp;ANDREW J. BENTALL MD, MBChB ,&nbsp;SUDHIR S. KUSHWAHA MD","doi":"10.1016/j.cardfail.2024.10.451","DOIUrl":"10.1016/j.cardfail.2024.10.451","url":null,"abstract":"<div><h3>Introduction</h3><div>Sirolimus (SRL) mitigates cardiac allograft vasculopathy (CAV) progression and confers renal protection after heart transplantation (HT). However, its safety and efficacy in patients undergoing combined heart and kidney transplantation (HKT) are unclear. This study aimed to investigate the impact of conversion from calcineurin inhibitors (CNIs) to SRL on CAV progression, renal function, and outcomes in HKT compared with isolated HT.</div></div><div><h3>Methods</h3><div>A cohort of 302 patients who underwent either HT only (n = 262) or HKT (n = 40) was analyzed. CAV progression was assessed by measuring the delta (Δ) annual change in plaque volume (PV) and plaque index (PI) using coronary intravenous ultrasound (IVUS). Clinical adverse outcomes included all-cause death and CAV-associated events. Overall, 217 (72%) patients were converted from CNI to SRL as primary immunosuppression. HT recipients were more likely to be converted to SRL than HKT recipients (74% vs. 55%, <em>P</em> = .01).</div></div><div><h3>Results</h3><div>HKT was associated with higher Δ PV (<em>P</em> = .01) and a trend toward higher ΔPI (<em>P</em> = .06) than HT only, but this association was attenuated after adjustment to SRL conversion. HKT was associated with similar risk of death (HR, 0.98; 95% CI 0.39–2.5, <em>P</em> = 0.97) and CAV-related events (HR, 1.6; 95% CI 0.91–2.8, <em>P</em><span> = .10). Conversion to SRL was associated with decreased risk of death and CAV-related events in the overall cohort. This association was not modified by the type of organ transplantation and without a significant effect on estimated glomerular filtration rate or proteinuria.</span></div></div><div><h3>Conclusion</h3><div>Conversion to sirolimus as a primary immunosuppressant could be effective for either HT-only or HKT recipients.</div></div>","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 9","pages":"Pages 1408-1416"},"PeriodicalIF":8.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142800926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Equip, Engage, Empower: Considerations for Effective Values Elicitation in the Population With LVAD 装备,参与,授权:在LVAD人群中有效的价值观启发的考虑。
IF 8.2 2区 医学
Journal of Cardiac Failure Pub Date : 2025-09-01 DOI: 10.1016/j.cardfail.2025.06.007
REBECCA S. STEINBERG MD, MSc , RASHONDA A. CARLISLE MD , CATHERINE SHELTON RN , SHELLEY A. HALL MD , ADITI NAYAK MD, MS
{"title":"Equip, Engage, Empower: Considerations for Effective Values Elicitation in the Population With LVAD","authors":"REBECCA S. STEINBERG MD, MSc ,&nbsp;RASHONDA A. CARLISLE MD ,&nbsp;CATHERINE SHELTON RN ,&nbsp;SHELLEY A. HALL MD ,&nbsp;ADITI NAYAK MD, MS","doi":"10.1016/j.cardfail.2025.06.007","DOIUrl":"10.1016/j.cardfail.2025.06.007","url":null,"abstract":"","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 9","pages":"Pages 1405-1407"},"PeriodicalIF":8.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144567478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Knowledge of Illness Trajectory and Symptoms of Heart Failure in Patients with Acute Coronary Syndrome 急性冠状动脉综合征患者对疾病轨迹和心力衰竭症状的了解。
IF 8.2 2区 医学
Journal of Cardiac Failure Pub Date : 2025-09-01 DOI: 10.1016/j.cardfail.2024.11.013
MOMOKO MASUDA PT , KAZUKI TOBITA PT , AYUMI GODA MD , DAISUKE FUJISAWA MD , SHINSUKE TAKEUCHI MD , KOHEI KOYAMA MD , SYOICHI TASHIRO MD , SHIN YAMADA MD , KYOKO SOEJIMA MD , TAKASHI KOHNO MD
{"title":"Knowledge of Illness Trajectory and Symptoms of Heart Failure in Patients with Acute Coronary Syndrome","authors":"MOMOKO MASUDA PT ,&nbsp;KAZUKI TOBITA PT ,&nbsp;AYUMI GODA MD ,&nbsp;DAISUKE FUJISAWA MD ,&nbsp;SHINSUKE TAKEUCHI MD ,&nbsp;KOHEI KOYAMA MD ,&nbsp;SYOICHI TASHIRO MD ,&nbsp;SHIN YAMADA MD ,&nbsp;KYOKO SOEJIMA MD ,&nbsp;TAKASHI KOHNO MD","doi":"10.1016/j.cardfail.2024.11.013","DOIUrl":"10.1016/j.cardfail.2024.11.013","url":null,"abstract":"<div><h3>Background</h3><div>Preventive management of heart failure (HF) should involve strategies to increase awareness of HF in patients with pre-HF and those at risk of HF. However, the perception of HF in patients with acute coronary syndrome<span> (ACS) remains unclear. This study aimed to assess patient understanding of the definition of HF for the public—that is, its illness trajectory (intermittent decline), impact on life expectancy (HF would limit life expectancy), and symptoms (shortness of breath, swelling)—that was introduced by the Japanese Circulation Society.</span></div></div><div><h3>Methods</h3><div>This cross-sectional, questionnaire-based study enrolled 209 emergently admitted patients with ACS who underwent a cardiac rehabilitation program at a single university-based hospital. We identified the clinical characteristics of patients who understood HF definition.</div></div><div><h3>Results</h3><div>Among the enrolled patients (median age, 69 years; males, 81.3%; 59.8% with ST-elevation myocardial infarction), 64.0% and 53.1% chose the correct answers regarding HF illness trajectory and impact on life expectancy, respectively. While 92.3% of the patients correctly chose shortness of breath as an HF symptom, 56.7% correctly chose swelling. Patient understanding of the definition of HF was associated with younger age, but not with HF risk (i.e., hypertension, diabetes, higher natriuretic peptide levels, lower left ventricular ejection fraction) and history of symptomatic HF.</div></div><div><h3>Conclusions</h3><div>Among patients with ACS who participated in the cardiac rehabilitation program in this cohort, patient understanding of HF definition was suboptimal. Effective measures to improve their understanding should be considered to enhance the prevention of HF.</div></div>","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 9","pages":"Pages 1430-1439"},"PeriodicalIF":8.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142836503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Value of Community in Heart Failure 社区在心力衰竭中的价值
IF 8.2 2区 医学
Journal of Cardiac Failure Pub Date : 2025-09-01 DOI: 10.1016/j.cardfail.2025.08.003
Anuradha Lala MD , Robert J. Mentz MD
{"title":"The Value of Community in Heart Failure","authors":"Anuradha Lala MD ,&nbsp;Robert J. Mentz MD","doi":"10.1016/j.cardfail.2025.08.003","DOIUrl":"10.1016/j.cardfail.2025.08.003","url":null,"abstract":"","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 9","pages":"Pages 1377-1378"},"PeriodicalIF":8.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145020931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Evaluation of the Heart Failure Somatic Perception Scale Using Item Response Theory 用项目反应理论评价心力衰竭躯体知觉量表。
IF 8.2 2区 医学
Journal of Cardiac Failure Pub Date : 2025-09-01 DOI: 10.1016/j.cardfail.2025.04.011
QUIN E. DENFELD PhD, RN, FAHA, FAAN, FHFSA , CORRINE Y. JURGENS PhD, RN, FAHA, FAAN, FHFSA , SHIRIN O. HIATT MPh, MS, RN , NATHAN F. DIECKMANN PhD , MARY ROBERTS DAVIS PhD, RN , S. ALBERT CAMACHO MD , CHRISTOPHER V. CHIEN MD, FACC , CHRISTOPHER S. LEE PhD, RN, FAHA, FAAN, FHFSA
{"title":"An Evaluation of the Heart Failure Somatic Perception Scale Using Item Response Theory","authors":"QUIN E. DENFELD PhD, RN, FAHA, FAAN, FHFSA ,&nbsp;CORRINE Y. JURGENS PhD, RN, FAHA, FAAN, FHFSA ,&nbsp;SHIRIN O. HIATT MPh, MS, RN ,&nbsp;NATHAN F. DIECKMANN PhD ,&nbsp;MARY ROBERTS DAVIS PhD, RN ,&nbsp;S. ALBERT CAMACHO MD ,&nbsp;CHRISTOPHER V. CHIEN MD, FACC ,&nbsp;CHRISTOPHER S. LEE PhD, RN, FAHA, FAAN, FHFSA","doi":"10.1016/j.cardfail.2025.04.011","DOIUrl":"10.1016/j.cardfail.2025.04.011","url":null,"abstract":"","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 9","pages":"Pages 1486-1489"},"PeriodicalIF":8.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144018793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dietary Inflammatory Score and Incident Heart Failure in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study 饮食炎症评分和心力衰竭在卒中地理和种族差异(REGARDS)研究中的影响。
IF 8.2 2区 医学
Journal of Cardiac Failure Pub Date : 2025-09-01 DOI: 10.1016/j.cardfail.2024.12.009
CHRISTINE M. PARK MD , LAUREN BALKAN MD , JOANNA B. RINGEL MPH , JAMES SHIKANY PhD , ROBIN BOSTICK MD, MPH , SUZANNE E. JUDD MD , CHANEL JONAS MD , PANKAJ ARORA MD , TODD M. BROWN MD, MSPH , RAEGAN DURANT MD, MPH , SCOTT HUMMEL MD, MS , ELIZABETH A. JACKSON MD , MADELINE R. STERLING MD, MPH , RYAN DEMMER PhD, MPH , MELANA YUZEFPOLSKAYA MD , EMILY B. LEVITAN ScD. , MONIKA M. SAFFORD MD , PARAG GOYAL MD, MSc
{"title":"Dietary Inflammatory Score and Incident Heart Failure in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study","authors":"CHRISTINE M. PARK MD ,&nbsp;LAUREN BALKAN MD ,&nbsp;JOANNA B. RINGEL MPH ,&nbsp;JAMES SHIKANY PhD ,&nbsp;ROBIN BOSTICK MD, MPH ,&nbsp;SUZANNE E. JUDD MD ,&nbsp;CHANEL JONAS MD ,&nbsp;PANKAJ ARORA MD ,&nbsp;TODD M. BROWN MD, MSPH ,&nbsp;RAEGAN DURANT MD, MPH ,&nbsp;SCOTT HUMMEL MD, MS ,&nbsp;ELIZABETH A. JACKSON MD ,&nbsp;MADELINE R. STERLING MD, MPH ,&nbsp;RYAN DEMMER PhD, MPH ,&nbsp;MELANA YUZEFPOLSKAYA MD ,&nbsp;EMILY B. LEVITAN ScD. ,&nbsp;MONIKA M. SAFFORD MD ,&nbsp;PARAG GOYAL MD, MSc","doi":"10.1016/j.cardfail.2024.12.009","DOIUrl":"10.1016/j.cardfail.2024.12.009","url":null,"abstract":"<div><h3>Background</h3><div>Inflammation plays a key role in the development of heart failure (HF), and diet is a known modifiable factor that modulates systemic inflammation. The dietary inflammatory score (DIS) is a tool that quantifies the inflammatory components of diet. We sought to determine whether the DIS is associated with incident HF events.</div></div><div><h3>Methods</h3><div><span>We examined a total of 17,975 participants without HF at baseline who were in the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort. The main exposure variable was the DIS quartile, which was derived from the Food Frequency Questionnaire<span> obtained at baseline study enrollment. The main outcome was an incident HF event, defined as hospitalization due to HF or death. To examine the association between the DIS and incident HF events, we conducted Cox proportional hazard regression modeling, adjusting for total </span></span>energy intake, sociodemographic factors and pro-inflammatory lifestyle behaviors.</div></div><div><h3>Results</h3><div><span>The sample mean age was 64 + 9.2 years, 55.8% were female, and 32.3% were Black. Over a median follow-up of 11.1 years, we observed 900 incident HF events, including 752 hospitalizations and 148 deaths due to HF. In an adjusted model, the highest DIS quartile (Q4) was associated with incident HF (HR 1.26 95% CI 1.03–1.54). Of note, these findings remained, even after adjusting for comorbid conditions and physiological parameters. In an age-stratified analysis, the association was present only in those aged &lt; 65 years (Q4: HR 1.65 95% CI 1.08–2.51). Moreover, the association was present for heart failure with reserved ejection fraction (Q4: HR 1.44 95% CI 1.07–1.94) but not for </span>heart failure with preserved ejection fraction.</div></div><div><h3>Conclusion</h3><div>The highest DIS quartile was associated with incident HF events. These findings indicate the potential value of specific dietary patterns to prevent HF.</div></div>","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 9","pages":"Pages 1440-1449"},"PeriodicalIF":8.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143005801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信